Non-alcoholic fatty liver disease
Conditions
Interventions
Experimental group:Patients will receive digital therapy
Sponsors
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Consistent with the diagnosis of NAFLD; 2. Age 18-65 years old, 24kg/m^2<=BMI<=35 kg/m^2; 3. Have the ability to operate mobile phone programs through learning; 4. Voluntarily participate in the study, and sign a written informed consent form, agreeing to follow the requirements of the trial protocol.
Exclusion criteria
Exclusion criteria: 1. Hepatotropic virus and non-hepatotropic virus infection, hereditary metabolic or autoimmune liver disease, drug/toxic/alcoholic/parasitic liver disease, biliary liver injury, or any end-stage liver disease; 2. Alanine aminotransferase greater than 200U/L; 3. The liver elasticity value is greater than 15 kPa; 4. Malignant tumors; 5. Acute myocardial infarction (MI), cerebrovascular accident, unstable angina, or cardiac insufficiency (NYHA functional grade II and above), hypertension level > within 3 months prior to enrollment= Grade 2 and current combination of 2 or more hypertensive drugs, etc.; 6. Diabetic patients or patients with poor glycemic control on insulin (HbA1c>9%); 7. Patients with chronic renal insufficiency (eGFR 400 IU/day), etc.; 12. Those who are pregnant or planning to become pregnant; 13. Patients who are participating in other clinical studies; 14. Other reasons deemed unsuitable for clinical investigators by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body Mass Index, BMI; | — |
Secondary
| Measure | Time frame |
|---|---|
| Controlled attenuation parameter values for Fibroscan assays;Alanine Aminotransferase; | — |
Countries
China
Contacts
Public ContactFan Jiangao
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed